The results of an independent study, published in the November/December issue of the American Journal of Therapeutics, reinforce the effectiveness of COLD-EEZE®, the nation's leading pharmacist recommended over-the-counter zinc cold remedy. Study findings showed that, when taken daily, COLD-EEZE® patented Zinc Gluconate Glycine formula statistically lessened the number of colds study participants experienced per year, reducing the incidence from 62% to 28%.

These findings were the result of an independent analysis of three years of clinical data at the Heritage School facility in Provo, Utah. The study also found that, when COLD-EEZE® was taken as a first-line treatment for the common cold, it statistically reduced the use of antibiotics for respiratory illnesses by 92%. Additionally, the study findings reinforce the original clinical trials, showing that COLD-EEZE® reduced the median duration of the common cold by approximately 4 days from 10 to 6 days.

Synergy Research Inc., an independent research organization, conducted the retrospective study comprised of more than 170,000 patient days on a student population of 378 adolescents ranging in age from 12 to 18 years. The average length of stay at Heritage School is 14 months.

The Heritage School introduced COLD-EEZE® lozenges to aid in the relief of the common cold in response to the high incidence of colds in 1999. COLD-EEZE® was administered symptomatically to treat common cold signs and symptoms in September 1999 and became standard practice at the facility in December 2000. Between December 2000 and May 2001, one dose of COLD-EEZE® was administered daily to the Heritage School students. Medical statistics then showed a decrease in cold episodes and the findings were reported to The Quigley Corporation.

The Heritage School Study Started September 1999 - Ended August 2001 School Aged Resident Population aged 12-18 378 patients were evaluated Study peer reviewed and published in The American Journal of Theraputics, vol. 9, no. 6 November 2002 Note: One (1) COLD-EEZE® lozenge provides 110% of the US RDA for zinc. Dissolving One (1) lozenge per day for an extended period of time poses little health risk. As with all medical treatments, please consult your medical practitioner prior to using COLD-EEZE® daily. For more safety information on COLD-EEZE®, click here.